Similar articles

• The value of beta TG/PF4 ratio in patients with high platelet count.

  Fabris F, Luzzatto G, Girolami A. Fabris F, et al. Thromb Haemost. 1985 Apr 22;53(2):288-9. Thromb Haemost. 1985. PMID: 2410998 No abstract available.
• Platelet activation in myeloproliferative disorders.

  Cortelazzo S, Viero P, Barbui T. Cortelazzo S, et al. Thromb Haemost. 1981 Jun 30;45(3):211-3. Thromb Haemost. 1981. PMID: 6169172
• Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.

  Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J. Lane DA, et al. Thromb Haemost. 1984 Oct 31;52(2):183-7. Thromb Haemost. 1984. PMID: 6084323
• Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders?

  Cella G, Scattolo N, Girolami A, Sasahara AA. Cella G, et al. Ric Clin Lab. 1984 Jan-Mar;14(1):9-18. doi: 10.1007/BF02905035. Ric Clin Lab. 1984. PMID: 6203164 Review.
• [Substances released by platelets. 1. beta-TG and PF 4].

  Niikura H. Niikura H. Rinsho Byori. 1985 Apr;Spec No 62:46-59. Rinsho Byori. 1985. PMID: 2411978 Review. Japanese. No abstract available.